Browsing Tag
EVOLVE-2
1 post
Verdiva Bio advances VRB-101 into late-stage positioning with fully enrolled Phase 2b obesity study
Find out why Verdiva Bio’s Phase 2b enrollment milestone could determine whether once-weekly oral GLP-1 drugs can truly challenge injectables.